Request for four (4) QuantStudio 5 real-time PCR systems (one for MOD1, one for

The Food and Drug Administration is seeking to acquire four QuantStudio 5 real-time PCR systems as part of an ORTS bundle purchase. These instruments are designed for immediate use with factory calibration and minimal maintenance requirements, featuring a small footprint with fixed blocks that support 96-well and 384-well consumables. The systems include a full-function touchscreen, remote monitoring capabilities, and optional cloud-based analysis modules for data sharing. Technical specifications include the ability to detect target quantity differences as low as 1.5-fold and multiplexing capabilities for up to six targets. The 96-well blocks utilize VeriFlex technology with six independent temperature zones for precise control and optimization. Additionally, the system includes software to ensure compliance with 21 CFR Part 11 regulations.